Literature DB >> 12160177

Clinical characteristics of necrotizing fasciitis caused by group G Streptococcus: case report and review of the literature.

Mamta Sharma1, Riad Khatib, Mohamad Fakih.   

Abstract

A 52-y-old diabetic male developed severe necrotizing fasciitis due to group G Streptococcus. A review of the English language literature revealed 8 additional cases. The mean age of the total of 9 cases was 65.5 y (range: 49-80 y) and the majority (n = 5; 55.6%) had no comorbid conditions. The duration of symptoms prior to presentation was 1-5 d (mean +/- SD = 2.5 +/- 1.5 d). Presenting manifestations were swelling with redness (6/6 cases; 100%), severe pain (5/6 cases; 83.3%) and blister formation (3/6 cases; 50%); blisters developed eventually in 5/6 (88.3%) patients. Muscle involvement was noted in 2 patients (22.2%). Progression to toxic shock-like syndrome occurred in 3 cases (33.3%). The organism was isolated from the involved sites in all cases. Bacteremia was documented in 1/3 patients. Treatment included antibiotics (n = 9) and varying degrees of surgical debridement (n = 8). The mortality rate was 33.3%; all patients who died developed toxic shock-like syndrome. These findings illustrate that, similar to Streptococcus pyogenes-induced fasciitis, necrotizing fasciitis due to group G Streptococcus can be severe and life-threatening. Early diagnosis, immediate surgical debridement and antibiotic therapy are essential in order to improve the outcome.

Entities:  

Mesh:

Year:  2002        PMID: 12160177     DOI: 10.1080/003655402320170318

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  12 in total

1.  emm and C-repeat region molecular typing of beta-hemolytic Streptococci in a tropical country: implications for vaccine development.

Authors:  Andrew C Steer; Graham Magor; Adam W J Jenney; Joseph Kado; Michael F Good; David McMillan; Michael Batzloff; Jonathan R Carapetis
Journal:  J Clin Microbiol       Date:  2009-06-10       Impact factor: 5.948

2.  Two unusual cases of severe soft tissue infection caused by Streptococcus dysgalactiae subsp. equisimilis.

Authors:  Bård Reiakvam Kittang; Nina Langeland; Steinar Skrede; Haima Mylvaganam
Journal:  J Clin Microbiol       Date:  2010-02-10       Impact factor: 5.948

3.  Multi-limb necrotizing fasciitis in a patient with rectal cancer.

Authors:  Shirley Yuk Wah Liu; Simon Siu Man Ng; Janet Fung Yee Lee
Journal:  World J Gastroenterol       Date:  2006-08-28       Impact factor: 5.742

4.  Necrotizing Soft Tissue Infections.

Authors:  Thomas M. File
Journal:  Curr Infect Dis Rep       Date:  2003-10       Impact factor: 3.725

5.  [Necrotizing fasciitis caused by group G streptococci].

Authors:  U Horas; U Herbst; A Hamann; S Ernst
Journal:  Orthopade       Date:  2008-06       Impact factor: 1.087

6.  Necrotizing fasciitis in a pediatric patient caused by lancefield group g streptococcus: case report and brief review of the literature.

Authors:  John Rausch; Marc Foca
Journal:  Case Rep Med       Date:  2011-12-27

7.  Prospective surveillance of invasive group a streptococcal disease, Fiji, 2005-2007.

Authors:  Andrew C Steer; Adam Jenney; Joseph Kado; Michael F Good; Michael Batzloff; Lepani Waqatakirewa; E Kim Mullholland; Jonathan R Carapetis
Journal:  Emerg Infect Dis       Date:  2009-02       Impact factor: 6.883

8.  Clinical Characteristics of Necrotizing Soft Tissue Infection and Early Toxic Shock-Like Syndrome Caused by Group G Streptococcus: Case Report and Review of Literature.

Authors:  Khalil Choucair; Katia El Jurdi; K James Kallail; Thomas A Moore
Journal:  Kans J Med       Date:  2021-06-21

9.  A five-year review of necrotising fasciitis in a tertiary referral unit.

Authors:  R A Swain; J C Hatcher; B S Azadian; N Soni; B De Souza
Journal:  Ann R Coll Surg Engl       Date:  2013-01       Impact factor: 1.891

10.  A case of emphysematous osteomyelitis of the midfoot: imaging findings and review of the literature.

Authors:  Marcela Mautone; Jessica Gray; Parm Naidoo
Journal:  Case Rep Radiol       Date:  2014-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.